Results 151 to 160 of about 41,260 (220)

Introduction of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) nasal polymerase chain reaction testing combined with pharmacist ordering and intervention reduces anti-MRSA antibiotic use in a multi-hospital system. [PDF]

Antimicrob Steward Healthc Epidemiol
Collins CD, Gupta C, Chou J, Shen J, Murphy H.   +4 more
europepmc   +1 more source

Anti-MRSA effects of synergism of recombinant lysostaphin with biosynthesized silver nanoparticles. [PDF]

Open Vet J
Saleh ZF, Mizher BM.
europepmc   +1 more source

Risk factors for anti-MRSA drug resistance

Risk factors for anti-MRSA drug resistance
Meticillin-resistant Staphylococcus aureus (MRSA)-related infections have recently been spreading and are difficult to control, partly because affected patients are frequently in a poor condition. This study retrospectively investigated recent MRSA-related infections focusing on the relationship between clinical risk factors and anti-MRSA drug ...
openaire  

Novel Anti-MRSA Peptide from Mangrove-Derived <i>Virgibacillus chiguensis</i> FN33 Supported by Genomics and Molecular Dynamics. [PDF]

Mar Drugs
Sermkaew N, Atipairin A, Boonruamkaew P, Krobthong S, Aonbangkhen C, Uchiyama J, Yingchutrakul Y, Songnaka N.   +7 more
europepmc   +1 more source

Design, eco-friendly synthesis, and molecular docking studies of isatin hybrids as promising therapeutic agents (anticancer, anticholinesterase inhibitor, α-glucosidase inhibitor, and anti-MRSA). [PDF]

RSC Adv
Seliem IA.
europepmc   +1 more source

Evaluating anti-MRSA antibiotic stewardship with a focus on trends in consumption and resistance in a tertiary hospital in Alexandria, Egypt from 2019 to 2023. [PDF]

Arch Public Health
Elmongui E, Zaki A, Elsheredy A, Elhameed AA.   +3 more
europepmc   +1 more source

In vitro and in vivo anti-MRSA activities of nosokomycins

In vitro and in vivo anti-MRSA activities of nosokomycins
The anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of nosokomycins A to D discovered in the silkworm-MRSA infection screening was investigated. The minimum inhibitory concentration (MIC) values of nosokomycins for authentic MRSA and S. aureus strains were calculated to be 0.06 to 2.0 μg/mL.
openaire  

Unveiling novel antimicrobial peptides from the ruminant gastrointestinal microbiomes: A deep learning-driven approach yields an anti-MRSA candidate. [PDF]

J Adv Res
Shen H, Li Y, Pi Q, Tian J, Xu X, Huang Z, Huang J, Pian C, Mao S.   +8 more
europepmc   +1 more source

First vanguard anti-MRSA agent approved [PDF]

Nature Biotechnology, 2014
openaire   +1 more source